Abstract:The final, formatted version of the article will be published soon. You have multiple emails registered with Frontiers: Please enter your email address: If you already have an account, please login You don't have a Frontiers account ? You can register here Gammaherpesviruses are widespread pathogens causing persistent infections linked to the development of numerous types of lymphomas in humans. During latency, most of the viral protein-coding genes are suppressed, facilitating evasion of adaptive immune recognition of protein antigens. In contrast, many noncoding RNA (ncRNA) molecules are expressed in infected cells and can regulate key cellular pathways while simultaneously evading adaptive immune recognition. To counteract this, many cells express internal pattern recognition receptors that can intrinsically sense ongoing infections and initiate cellular defenses. Murine gammaherpesvirus 68 (MHV68) is a valuable model to study in vivo aspects of gammaherpesvirus pathogenesis. The MHV68 ncRNA TMER4 (tRNA-miRNA-encoding RNA 4) promotes lymph node egress of infected B cells: in the absence of TMER4, MHV68-infected B cells accumulate in the lymph node in a manner similar to B cells activated through specific antigen encounter. Based on this finding, we hypothesized that TMER4 may alter intrinsic immune activation. In research described here, we aimed to explore the immunomodulatory functions of TMER4 by evaluating its impact on signaling through the critical immune sensors Toll-like receptor 4 (TLR4), TLR3, TLR7, and retinoic acid-inducible gene I (RIG-I). To accomplish this, we developed a system to test noncoding RNAs using commercially available reporter cell lines. We optimized the experimental procedure to ensure ncRNA expression and to quantify immune sensory molecule induction or inhibition by the expressed ncRNA. Though TMER4 did not alter TLR or RIG-I signaling, this study provides a clear experimental framework that can be applied to test other small ncRNAs for their impact on various innate immune sensor proteins.

Toll-like receptor (TLR) 3 as a surrogate sensor of retroviral infection in human cells.

Toll-like Receptor 3 and Tumor Immunity

Toll-like receptor 3 and its signaling pathway

Toll-like receptor 3 signaling contributes to the expression of a neutrophil chemoattractant, CXCL1 in human mesangial cells

TLR3/TRIF and MAVS Signaling Is Essential in Regulating Mucosal T Cell Responses during Rotavirus Infection

Estrogen Receptor Alpha Inhibits RLR-mediated Immune Response Via Ubiquitinating TRAF3.

Research Progress in Xenotropic Murine Leukemia Virus-Related Virus——A New Human Retrovirus

TLR3 Serves as a Prognostic Biomarker and Associates with Immune Infiltration in the Renal Clear Cell Carcinoma Microenvironment

Regulation Of Viral Infection-Induced Airway Remodeling Cytokine Production By The Tlr3-Egfr Signaling Pathway In Human Bronchial Epithelial Cells

R-848 triggers the expression of TLR7/8 and suppresses HIV replication in monocytes

Biology and pathophysiology of the new human retrovirus XMRV and its association with human disease

The E3 Ubiquitin Ligase Triad3A Negatively Regulates the RIG-I/MAVS Signaling Pathway by Targeting TRAF3 for Degradation

TRAF3IP3 mediates the recruitment of TRAF3 to MAVS for antiviral innate immunity

Toll-like Receptor 3 Signaling Inhibits Double-Stranded RNA-induced Apoptosis of Macrophages (168.21)

Evaluation of immune sensor responses to a viral small noncoding RNA

Human RNase3 immune modulation by catalytic-dependent and independent modes in a macrophage-cell line infection model

Negative Regulation of RIG-I by Tim-3 Promotes H1N1 Infection.

Association of Toll-Like Receptor 3 Polymorphisms with Kaposi's Sarcoma-Associated Herpesvirus Infection Among Human Immunodeficiency Virus-Infected Individuals in Xinjiang, China

TLR-9 contributes to the antiviral innate immune sensing of rodent parvoviruses MVMp and H-1PV by normal human immune cells

Sensing of HIV-1 by TLR8 Activates Human T Cells and Reverses Latency

Bruton's tyrosine kinase phosphorylates Toll-like receptor 3 to initiate antiviral response